VESANOID Side Effects

5938039-7 | Myelodysplastic Syndrome
on Oct 17, 2008 Female patient from JAPAN , 51 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: myelodysplastic syndrome. Vesanoid dosage: . During the same period patient was treated with IDAMYCIN (68 Mg In Total) (View Idamycin Review and Idamycin Label ), CYLOCIDE (980mg In Total) (View Cylocide Review and Cylocide Label ), ADRIACIN (204 Mg In Total) (View Adriacin Review and Adriacin Label ).

5915155-7 | Myelodysplastic Syndrome
Patient was taking Vesanoid (View Usage). Patient had the following side effects: myelodysplastic syndrome on Oct 01, 2008 from JAPAN Additional patient health information: Female patient , 51 years of age, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: . During the same period patient was treated with IDARUBICIN HCL (68 Mg In Total) (View Idarubicin Hcl Review and Idarubicin Hcl Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ADRIAMYCIN PFS (204 Mg In Total) (View Adriamycin Pfs Review and Adriamycin Pfs Label ).

5907676-8 | Disseminated Intravascular Coagulation, Multi-organ Failure, Pulmonary Haemorrhage
Adverse event was reported on Nov 24, 1997 by a Female patient taking Vesanoid (View Usage) (Dosage: ) . Location: UNITED STATES , 30 years of age, After Vesanoid was administered, patient had the following side effects: disseminated intravascular coagulation, multi-organ failure, pulmonary haemorrhage. Patient was hospitalized.

5871776-1 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Aug 26, 2008 Female patient from UNITED STATES , weighting 190.9 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased. Vesanoid dosage: . During the same period patient was treated with TRISENOX (Form Reported As: Intravenous Drip) (View Trisenox Review and Trisenox Label ), ZOFRAN (View Zofran Review and Zofran Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ).


5865696-6 | Atrioventricular Block Complete, Pericardial Effusion
on Aug 18, 2008 Male patient from JAPAN , 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient had the following side effects: atrioventricular block complete, pericardial effusion. Vesanoid dosage: .

5854012-1 | Condition Aggravated, Disseminated Intravascular Coagulation, Pulmonary Haemorrhage, Respiratory Failure
Patient was taking Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: condition aggravated, disseminated intravascular coagulation, pulmonary haemorrhage, respiratory failure on Aug 11, 2008 from BRAZIL Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with acute myeloid leukaemia and. Vesanoid dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MEROPENEM (View Meropenem Review and Meropenem Label ). Patient was hospitalized.

5843915-X | Atrioventricular Block Complete, Pericardial Effusion
Adverse event was reported on Aug 01, 2008 by a Male patient taking Vesanoid (View Usage) (Dosage: ) was diagnosed with acute promyelocytic leukaemia and. Location: JAPAN , 66 years of age, Patient experienced the following unwanted or unexpected effects: atrioventricular block complete, pericardial effusion.

5760928-7 | Ill-defined Disorder, Renal Failure Acute, Retinoic Acid Syndrome
on May 26, 2008 Male patient from CHILE , 60 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient had the following side effects: ill-defined disorder, renal failure acute, retinoic acid syndrome. Vesanoid dosage: . Patient was hospitalized.

5740566-2 | Pulmonary Alveolar Haemorrhage
on May 07, 2008 Male patient from JAPAN , weighting 143.3 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: pulmonary alveolar haemorrhage. Vesanoid dosage: In The Morning: 30 Mg, In The Day Time: 30 Mg, In The Evening: 20 Mg.. During the same period patient was treated with GRAN (View Gran Review and Gran Label ), CYLOCIDE (Route: Injectable (not Otherwise Specified)) (View Cylocide Review and Cylocide Label ), IDAMYCIN (Route: Intravenous (not Otherwise Specified).) (View Idamycin Review and Idamycin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), RADICUT (View Radicut Review and Radicut Label ), MAXIPIME (View Maxipime Review and Maxipime Label ).

5734822-1 | Bronchopulmonary Aspergillosis, Dyspnoea, Lung Infiltration, Pyrexia, Retinoic Acid Syndrome
Patient was taking Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, dyspnoea, lung infiltration, pyrexia, retinoic acid syndrome on Apr 30, 2008 from SPAIN Additional patient health information: Male patient , 67 years of age, . Vesanoid dosage: Form Soft Capsule. Patient was hospitalized.

5733301-5 | C-reactive Protein Increased
Adverse event was reported on Apr 28, 2008 by a Male patient taking Vesanoid (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia and. Location: JAPAN , 70 years of age, Patient had the following side effects: c-reactive protein increased.

5708017-1 | Cardiac Enzymes Increased, Chest Pain
on Apr 11, 2008 Male patient from UNITED STATES , 46 years of age, was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: cardiac enzymes increased, chest pain (What is chest pain?). Vesanoid dosage: . During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), ACYCLOVIR (Frequency: Every 12 Hours) (View Acyclovir Review and Acyclovir Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CLARITIN (View Claritin Review and Claritin Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

5694592-2 | Neutropenia, Platelet Count Decreased, Retinal Haemorrhage, Vasculitis
on Mar 24, 2008 Female patient from JAPAN , 37 years of age, was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, platelet count decreased, retinal haemorrhage, vasculitis (What is vasculitis?). Vesanoid dosage: . During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), SELBEX (Form: Oral Formulation (not Otherwise Specified)) (View Selbex Review and Selbex Label ), BIOFERMIN (Form: Oral Formulation (not Otherwise Specified)) (View Biofermin Review and Biofermin Label ), POLYMYCIN B SULFATE (View Polymycin B Sulfate Review and Polymycin B Sulfate Label ), MAGMITT (View Magmitt Review and Magmitt Label ).

5690330-8 |
Patient was taking Vesanoid (View Usage). on Apr 12, 2002 from UNITED STATES Additional patient health information: Female patient , child 11 years of age, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: Regimen Reported As 70mg Q 12hr.. During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), TYLENOL (CAPLET) (Dosing Regimen Reported As 650mg Prn 4-6.) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CELEBREX (View Celebrex Review and Celebrex Label ), CEFTAZIDIME SODIUM (View Ceftazidime Sodium Review and Ceftazidime Sodium Label ), CARAFATE (View Carafate Review and Carafate Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ).

5629935-9 | C-reactive Protein Increased
Adverse event was reported on Feb 08, 2008 by a Male patient taking Vesanoid (View Usage) (Dosage: ) . Location: JAPAN , 70 years of age, After Vesanoid was administered, patient had the following side effects: c-reactive protein increased.

5626997-X | Asthenia, Blood Bilirubin Increased, Blood Sodium Decreased, Febrile Neutropenia, Haematoma, Infection, Mucosal Inflammation, Myocardial Infarction, Pleural Effusion
on Sep 14, 2007 Male patient from UNITED STATES , 77 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood bilirubin increased, blood sodium decreased, febrile neutropenia, haematoma, infection (What is infection?), mucosal inflammation, myocardial infarction, pleural effusion. Vesanoid dosage: 10 Mg 2 Per Day. Patient was hospitalized.

5626995-6 | Headache, Pleural Effusion
on Jun 14, 2007 Female patient from UNITED STATES , 23 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient had the following side effects: headache (What is headache?), pleural effusion. Vesanoid dosage: 70 Mg.

5598648-4 | Panniculitis
Patient was taking Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: panniculitis on Jan 11, 2008 from FRANCE Additional patient health information: Male patient , 73 years of age, . Vesanoid dosage: 50 Mg In The Morning And 40 Mg In The Evening. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LEXOMIL (Dosage Regimen: 0.5 Dose Daily) (View Lexomil Review and Lexomil Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), DEXAMETHASONE TAB (Formulation: Injectable Solution) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CLAFORAN (Formulation: Injectable Solution) (View Claforan Review and Claforan Label ). Patient was hospitalized.

5577966-X | Capillary Leak Syndrome
Adverse event was reported on Dec 21, 2007 by a Female patient taking Vesanoid (View Usage) (Dosage: Dosage Reported:4-0-4) was diagnosed with acute myeloid leukaemia and. Location: AUSTRIA , 23 years of age, Patient experienced the following unwanted or unexpected effects: capillary leak syndrome.

5567059-X | Retinoic Acid Syndrome, Ventricular Fibrillation
on Jan 20, 2006 Female patient from JAPAN , 75 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient had the following side effects: retinoic acid syndrome, ventricular fibrillation. Vesanoid dosage: . During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), NOVANTRONE (View Novantrone Review and Novantrone Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ACLARUBICIN HYDROCHLORIDE (View Aclarubicin Hydrochloride Review and Aclarubicin Hydrochloride Label ), GRAN (View Gran Review and Gran Label ).

5565308-5 | Disseminated Intravascular Coagulation, Rash Erythematous, Retinoic Acid Syndrome
on Feb 21, 2003 Male patient from JAPAN , 75 years of age, weighting 174.2 lb, was diagnosed with acute promyelocytic leukaemia, infection (What is infection?) and was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: disseminated intravascular coagulation, rash erythematous, retinoic acid syndrome. Vesanoid dosage: . During the same period patient was treated with FOY (View Foy Review and Foy Label ), HEPARIN (View Heparin Review and Heparin Label ), PENTCILLIN (View Pentcillin Review and Pentcillin Label ), POLYMYXIN B SULFATE (View Polymyxin B Sulfate Review and Polymyxin B Sulfate Label ), LAC B (View Lac-b Review and Lac-b Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

5529300-9 | Asthenia, Cerebral Haemorrhage, Confusional State, Dizziness, Dry Skin, Fatigue, Flushing, Grand Mal Convulsion
Patient was taking Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cerebral haemorrhage, confusional state, dizziness (What is dizziness?), dry skin, fatigue, flushing, grand mal convulsion on Nov 20, 2007 from UNITED STATES Additional patient health information: Male patient , 50 years of age, . Vesanoid dosage: Route Reported As Oral.. Patient was hospitalized.

5526763-X | Pulmonary Alveolar Haemorrhage
Adverse event was reported on Nov 15, 2007 by a Male patient taking Vesanoid (View Usage) (Dosage: In The Morning: 30 Mg, In The Day Time: 30 Mg, In The Evening: 20 Mg.) was diagnosed with acute promyelocytic leukaemia and. Location: JAPAN , 65 years of age, weighting 143.3 lb, Patient had the following side effects: pulmonary alveolar haemorrhage. During the same period patient was treated with GRAN (View Gran Review and Gran Label ), CYLOCIDE (Route: Injectable (not Otherwise Specified)) (View Cylocide Review and Cylocide Label ), IDAMYCIN (Route: Intravenous (not Otherwise Specified).) (View Idamycin Review and Idamycin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), RADICUT (View Radicut Review and Radicut Label ), MAXIPIME (View Maxipime Review and Maxipime Label ).

5510243-1 | Asthenia, Cerebral Haemorrhage, Confusional State, Dizziness, Dry Skin, Fatigue, Flushing, Grand Mal Convulsion
on Oct 30, 2007 Male patient from UNITED STATES , 50 years of age, was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: asthenia, cerebral haemorrhage, confusional state, dizziness (What is dizziness?), dry skin, fatigue, flushing, grand mal convulsion. Vesanoid dosage: Route Reported As Oral.. Patient was hospitalized.

5503048-9 | Pulmonary Alveolar Haemorrhage
on Oct 22, 2007 Male patient from JAPAN , 65 years of age, weighting 143.3 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary alveolar haemorrhage. Vesanoid dosage: . During the same period patient was treated with GRAN (View Gran Review and Gran Label ), CYLOCIDE (Route: Injectable (not Otherwise Specified)) (View Cylocide Review and Cylocide Label ), IDAMYCIN (Route: Intravenous (not Otherwise Specified).) (View Idamycin Review and Idamycin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), RADICUT (View Radicut Review and Radicut Label ).

5499774-0 | Pulmonary Alveolar Haemorrhage, Retinoic Acid Syndrome
Patient was taking Vesanoid (View Usage). Patient had the following side effects: pulmonary alveolar haemorrhage, retinoic acid syndrome on Oct 17, 2007 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: .

5499772-7 | Pulmonary Alveolar Haemorrhage
Adverse event was reported on Oct 16, 2007 by a Male patient taking Vesanoid (View Usage) (Dosage: 30mg In The Daytime, 20 Mg In The Evening) was diagnosed with acute promyelocytic leukaemia and. Location: JAPAN , 65 years of age, weighting 143.3 lb, After Vesanoid was administered, patient had the following side effects: pulmonary alveolar haemorrhage. During the same period patient was treated with GRAN (View Gran Review and Gran Label ), CYLOCIDE (Route: Injectable (not Otherwise Specified)) (View Cylocide Review and Cylocide Label ), IDAMYCIN (Route: Intravenous (not Otherwise Specified).) (View Idamycin Review and Idamycin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ).

5487119-1 | Pulmonary Alveolar Haemorrhage, Respiratory Failure
on Oct 04, 2007 Male patient from JAPAN , 65 years of age, weighting 143.3 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary alveolar haemorrhage, respiratory failure. Vesanoid dosage: 30mg In The Daytime, 20 Mg In The Evening. During the same period patient was treated with GRAN (View Gran Review and Gran Label ), CYLOCIDE (Route: Injectable (not Otherwise Specified.) (View Cylocide Review and Cylocide Label ), IDAMYCIN (Route: Intravenous (not Otherwise Specified).) (View Idamycin Review and Idamycin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ).

5485298-3 | Blood Pressure Decreased, Cardio-respiratory Arrest, Heart Rate Decreased
on Oct 10, 2007 Male patient from UNITED STATES , 34 years of age, weighting 134.9 lb, was diagnosed with leukaemia and was treated with Vesanoid (View Usage). Patient had the following side effects: blood pressure decreased, cardio-respiratory arrest, heart rate decreased. Vesanoid dosage: 40 Mg / 40 Ml Q12hr - Via Ngtube-.

5470967-1 | Disseminated Intravascular Coagulation, Hypoxia, Respiratory Failure, Retinoic Acid Syndrome
Patient was taking Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: disseminated intravascular coagulation, hypoxia, respiratory failure, retinoic acid syndrome on Sep 19, 2007 from UNITED STATES Additional patient health information: Female patient , 19 years of age, weighting 164.2 lb, was diagnosed with prophylaxis and. Vesanoid dosage: Route Was Reported As Both Nasogastric And Oral Lot # Was Reported As U0020. During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), ACYCLOVIR (The Dose Was Changed To 200mg Po Every 24 Hours For 2 Days (nos)and Then Every 12 Hours (26 April 2+) (View Acyclovir Review and Acyclovir Label ), UNASYN (View Unasyn Review and Unasyn Label ), DECADRON (Route Reported As Both Oral And Intravenous, 10mg Every 12 Hours) (View Decadron Review and Decadron Label ), LORAZEPAM (One Time Dose) (View Lorazepam Review and Lorazepam Label ), PERCOCET (Reported As 5/325mg, One Tablet Every 6 Hours As Needed) (View Percocet Review and Percocet Label ). Patient was hospitalized.

5470963-4 | Abortion Spontaneous
Adverse event was reported on Sep 19, 2007 by a Female patient taking Vesanoid (View Usage) (Dosage: 40 Mg Every 12 Hours. Route Was Reported As Both Oral And Nasogastric Tube. Lot #u0016) was diagnosed with prophylaxis and. Location: UNITED STATES , 19 years of age, weighting 164.2 lb, Patient experienced the following unwanted or unexpected effects: abortion spontaneous. During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), ACYCLOVIR (The Patient's Dosage Was Changed To 200mg Every 24 Hours For 2 Days (nos) And Then Every 12 Hours (+) (View Acyclovir Review and Acyclovir Label ), UNASYN (View Unasyn Review and Unasyn Label ), DECADRON (Route Reported As Both Oral And Intravenous) (View Decadron Review and Decadron Label ), LORAZEPAM (One Time Dose) (View Lorazepam Review and Lorazepam Label ), PERCOCET (5/325mg, One Tablet Every Six Hours As Needed) (View Percocet Review and Percocet Label ).

5468406-X | Asthenia, Cerebral Haemorrhage, Confusional State, Dizziness, Dry Skin, Fatigue, Flushing, Grand Mal Convulsion
on Sep 17, 2007 Male patient from UNITED STATES , 50 years of age, was treated with Vesanoid (View Usage). Patient had the following side effects: asthenia, cerebral haemorrhage, confusional state, dizziness (What is dizziness?), dry skin, fatigue, flushing, grand mal convulsion. Vesanoid dosage: Route Reported As Oral.. Patient was hospitalized.

5439512-0 | Pulmonary Alveolar Haemorrhage
on Aug 20, 2007 Male patient from JAPAN , 65 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: pulmonary alveolar haemorrhage. Vesanoid dosage: In The Daytime, In The Evening: 20 Mg.. During the same period patient was treated with CYLOCIDE (Route: Injectable (not Otherwise Specified.) (View Cylocide Review and Cylocide Label ), IDAMYCIN (Route: Intravenous (not Otherwise Specified).) (View Idamycin Review and Idamycin Label ), GRAN (View Gran Review and Gran Label ).

5413778-5 | Cerebral Haemorrhage, Confusional State, Dry Skin, Flushing
Patient was taking Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, confusional state, dry skin, flushing on Aug 02, 2007 from UNITED STATES Additional patient health information: Male patient , 50 years of age, . Vesanoid dosage: Route Reported As Oral.. Patient was hospitalized.

5411271-7 | Abortion Spontaneous
Adverse event was reported on Jul 30, 2007 by a Female patient taking Vesanoid (View Usage) (Dosage: 40 Mg Every 12 Hours. Route Was Reported As Both Oral And Nasogastric Tube.) was diagnosed with prophylaxis and. Location: UNITED STATES , 19 years of age, weighting 164.2 lb, Patient had the following side effects: abortion spontaneous. During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), ACYCLOVIR (The Patient's Dosage Was Changed To 200mg Every 24 Hours For 2 Days (nos) And Then Every 12 Hours (+) (View Acyclovir Review and Acyclovir Label ), UNASYN (View Unasyn Review and Unasyn Label ), DECADRON (Route Reported As Both Oral And Intravenous) (View Decadron Review and Decadron Label ), LORAZEPAM (One Time Dose) (View Lorazepam Review and Lorazepam Label ), PERCOCET (5/325mg, One Tablet Every Six Hours As Needed) (View Percocet Review and Percocet Label ).

5411270-5 | Disseminated Intravascular Coagulation, Hypoxia, Respiratory Failure, Retinoic Acid Syndrome
on Jul 30, 2007 Female patient from UNITED STATES , 19 years of age, weighting 164.2 lb, was diagnosed with prophylaxis and was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: disseminated intravascular coagulation, hypoxia, respiratory failure, retinoic acid syndrome. Vesanoid dosage: Route Was Reported As Both Nasogastric And Oral. During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), ACYCLOVIR (The Dose Was Changed To 200mg Po Every 24 Hours For 2 Days (nos)and Then Every 12 Hours (26 April 2+) (View Acyclovir Review and Acyclovir Label ), UNASYN (View Unasyn Review and Unasyn Label ), DECADRON (Route Reported As Both Oral And Intravenous, 10mg Every 12 Hours) (View Decadron Review and Decadron Label ), LORAZEPAM (One Time Dose) (View Lorazepam Review and Lorazepam Label ), PERCOCET (Reported As 5/325mg, One Tablet Every 6 Hours As Needed) (View Percocet Review and Percocet Label ). Patient was hospitalized.

5405229-1 | Cardiac Failure, Interstitial Lung Disease, Respiratory Failure
on Jul 25, 2007 Male patient from JAPAN , 68 years of age, weighting 220.5 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, interstitial lung disease, respiratory failure. Vesanoid dosage: . During the same period patient was treated with IDAMYCIN (View Idamycin Review and Idamycin Label ), FOY (View Foy Review and Foy Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ).

5392302-X | Cardiac Failure, Interstitial Lung Disease, Respiratory Failure
Patient was taking Vesanoid (View Usage). Patient had the following side effects: cardiac failure, interstitial lung disease, respiratory failure on Jul 10, 2007 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 220.5 lb, was diagnosed with acute promyelocytic leukaemia and. Vesanoid dosage: . During the same period patient was treated with IDAMYCIN (View Idamycin Review and Idamycin Label ), FOY (View Foy Review and Foy Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ).

5356885-8 | Abortion Spontaneous
Adverse event was reported on Jun 05, 2007 by a Female patient taking Vesanoid (View Usage) (Dosage: 40 Mg Every 12 Hours) . Location: UNITED STATES , 19 years of age, weighting 164.2 lb, After Vesanoid was administered, patient had the following side effects: abortion spontaneous. During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ).

5355714-6 | Disseminated Intravascular Coagulation, Hypoxia, Respiratory Failure, Retinoic Acid Syndrome
on Jun 05, 2007 Female patient from UNITED STATES , 19 years of age, weighting 164.2 lb, was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, hypoxia, respiratory failure, retinoic acid syndrome. Vesanoid dosage: . During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ). Patient was hospitalized.

5344176-0 | Histiocytosis Haematophagic
on May 23, 2007 Male patient from JAPAN , 19 years of age, weighting 126.1 lb, was treated with Vesanoid (View Usage). Patient had the following side effects: histiocytosis haematophagic. Vesanoid dosage: . During the same period patient was treated with FOY (View Foy Review and Foy Label ), FUTHAN (View Futhan Review and Futhan Label ), MODACIN (View Modacin Review and Modacin Label ), TOBRACIN (View Tobracin Review and Tobracin Label ), ZANTAC (View Zantac Review and Zantac Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

5325102-7 | Blood Lactate Dehydrogenase Increased, Dyspnoea, Hypotension, Pyrexia, Renal Failure Acute, Retinoic Acid Syndrome, Rhabdomyolysis, Transaminases Increased
Patient was taking Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: blood lactate dehydrogenase increased, dyspnoea, hypotension, pyrexia, renal failure acute, retinoic acid syndrome, rhabdomyolysis, transaminases increased on May 02, 2007 from BRAZIL Additional patient health information: Male patient , 27 years of age, . Vesanoid dosage: . During the same period patient was treated with DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

5323714-8 | Respiratory Failure
Adverse event was reported on May 03, 2007 by a Female patient taking Vesanoid (View Usage) (Dosage: ) . Location: UNITED STATES , 19 years of age, Patient experienced the following unwanted or unexpected effects: respiratory failure. Patient was hospitalized.

5289565-8 | Leukoencephalopathy, Progressive Multifocal Leukoencephalopathy
on Apr 02, 2007 Male patient from CANADA , 45 years of age, weighting 251.3 lb, was treated with Vesanoid (View Usage). Patient had the following side effects: leukoencephalopathy, progressive multifocal leukoencephalopathy. Vesanoid dosage: . During the same period patient was treated with IDAMYCIN (Form Reported As Vial.) (View Idamycin Review and Idamycin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ). Patient was hospitalized.

5288968-5 | Acute Promyelocytic Leukaemia, Malignant Neoplasm Progression
on May 09, 2006 Female patient from UNITED STATES , child 2 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: acute promyelocytic leukaemia, malignant neoplasm progression. Vesanoid dosage: 10 Mg 2 Per Day Oral.

5288953-3 | Retinoic Acid Syndrome
Patient was taking Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: retinoic acid syndrome on Mar 29, 2006 from UNITED STATES Additional patient health information: Male patient , 58 years of age, was diagnosed with acute myeloid leukaemia and. Vesanoid dosage: . Patient was hospitalized.

5286418-6 | Congenital Endocrine Anomaly, Primary Hypothyroidism
Adverse event was reported on Mar 27, 2007 by a Male patient taking Vesanoid (View Usage) (Dosage: The Patient Was Scheduled To Take Vesanoid For A Total Of 1 Year. He Was In His 3rd Or 4th Round A+) . Location: UNITED STATES , 38 years of age, Patient had the following side effects: congenital endocrine anomaly, primary hypothyroidism.

5262849-5 | Haemorrhage Intracranial, Retinoic Acid Syndrome
on Mar 02, 2007 Male patient from JAPAN , child 11 years of age, weighting 127.9 lb, was treated with Vesanoid (View Usage). After Vesanoid was administered, patient had the following side effects: haemorrhage intracranial, retinoic acid syndrome. Vesanoid dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BAKTAR (View Baktar Review and Baktar Label ), KYTRIL (View Kytril Review and Kytril Label ). Patient was hospitalized.

5245230-4 | Primary Hypothyroidism
on Feb 16, 2007 Male patient from UNITED STATES , 38 years of age, was treated with Vesanoid (View Usage). Patient experienced the following unwanted or unexpected effects: primary hypothyroidism. Vesanoid dosage: The Patient Was Scheduled To Take Vesanoid For A Total Of 1 Year. He Was In His 3rd Or 4th Round A+.

5241641-1 | Leukoencephalopathy, Progressive Multifocal Leukoencephalopathy
Patient was taking Vesanoid (View Usage). Patient had the following side effects: leukoencephalopathy, progressive multifocal leukoencephalopathy on Feb 09, 2007 from CANADA Additional patient health information: Male patient , 45 years of age, weighting 251.3 lb, . Vesanoid dosage: . During the same period patient was treated with IDAMYCIN (Form Reported As Vial.) (View Idamycin Review and Idamycin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ). Patient was hospitalized.